Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
1953 1
1955 1
1959 1
1966 1
1967 2
1968 3
1969 4
1970 5
1971 4
1972 4
1973 2
1974 3
1975 3
1976 1
1977 7
1978 2
1979 3
1980 6
1981 10
1982 4
1983 6
1984 5
1985 6
1986 17
1987 12
1988 6
1989 11
1990 9
1991 4
1992 4
1993 4
1994 9
1995 3
1996 4
1997 3
1998 4
1999 11
2000 4
2001 3
2002 3
2003 10
2004 4
2005 11
2006 6
2007 10
2008 9
2009 5
2010 11
2011 7
2012 7
2013 12
2014 5
2015 7
2016 9
2017 5
2018 7
2019 5
2020 2
2021 3
2022 3
2023 2
2024 1

Text availability

Article attribute

Article type

Publication date

Search Results

321 results

Results by year

Filters applied: . Clear all
Page 1
Monoclonal TCR-redirected tumor cell killing.
Liddy N, Bossi G, Adams KJ, Lissina A, Mahon TM, Hassan NJ, Gavarret J, Bianchi FC, Pumphrey NJ, Ladell K, Gostick E, Sewell AK, Lissin NM, Harwood NE, Molloy PE, Li Y, Cameron BJ, Sami M, Baston EE, Todorov PT, Paston SJ, Dennis RE, Harper JV, Dunn SM, Ashfield R, Johnson A, McGrath Y, Plesa G, June CH, Kalos M, Price DA, Vuidepot A, Williams DD, Sutton DH, Jakobsen BK. Liddy N, et al. Among authors: jakobsen bk. Nat Med. 2012 Jun;18(6):980-7. doi: 10.1038/nm.2764. Nat Med. 2012. PMID: 22561687
NY-ESO-1-specific TCR-engineered T cells mediate sustained antigen-specific antitumor effects in myeloma.
Rapoport AP, Stadtmauer EA, Binder-Scholl GK, Goloubeva O, Vogl DT, Lacey SF, Badros AZ, Garfall A, Weiss B, Finklestein J, Kulikovskaya I, Sinha SK, Kronsberg S, Gupta M, Bond S, Melchiori L, Brewer JE, Bennett AD, Gerry AB, Pumphrey NJ, Williams D, Tayton-Martin HK, Ribeiro L, Holdich T, Yanovich S, Hardy N, Yared J, Kerr N, Philip S, Westphal S, Siegel DL, Levine BL, Jakobsen BK, Kalos M, June CH. Rapoport AP, et al. Among authors: jakobsen bk. Nat Med. 2015 Aug;21(8):914-921. doi: 10.1038/nm.3910. Epub 2015 Jul 20. Nat Med. 2015. PMID: 26193344 Free PMC article.
Obituary.
Jakobsen BK, Dickmeiss E. Jakobsen BK, et al. HLA. 2016 Jun;87(6):411-2. doi: 10.1111/tan.12818. HLA. 2016. PMID: 27283134 No abstract available.
Fludarabine and neurotoxicity in engineered T-cell therapy.
Lowe KL, Mackall CL, Norry E, Amado R, Jakobsen BK, Binder G. Lowe KL, et al. Among authors: jakobsen bk. Gene Ther. 2018 Jun;25(3):176-191. doi: 10.1038/s41434-018-0019-6. Epub 2018 May 7. Gene Ther. 2018. PMID: 29789639
Badminton injuries.
Krøner K, Schmidt SA, Nielsen AB, Yde J, Jakobsen BW, Møller-Madsen B, Jensen J. Krøner K, et al. Among authors: jakobsen bw. Br J Sports Med. 1990 Sep;24(3):169-72. doi: 10.1136/bjsm.24.3.169. Br J Sports Med. 1990. PMID: 2078802 Free PMC article.
[Tissue types].
Svejgaard A, Jakobsen BK, Dickmeiss E. Svejgaard A, et al. Among authors: jakobsen bk. Ugeskr Laeger. 2003 Dec 8;165(50):4834-6. Ugeskr Laeger. 2003. PMID: 14716898 Danish. No abstract available.
Novel TCR-based biologics: mobilising T cells to warm 'cold' tumours.
Lowe KL, Cole D, Kenefeck R, OKelly I, Lepore M, Jakobsen BK. Lowe KL, et al. Among authors: jakobsen bk. Cancer Treat Rev. 2019 Jul;77:35-43. doi: 10.1016/j.ctrv.2019.06.001. Epub 2019 Jun 12. Cancer Treat Rev. 2019. PMID: 31207478 Free article. Review.
321 results